Bioorganic and Medicinal Chemistry Letters p. 3123 - 3126 (1999)
Update date:2022-08-04
Topics:
Yoshida, Yoshiki
Matsuda, Keiji
Sasaki, Hiroshi
Matsumoto, Yoshimi
Matsumoto, Satoru
Takasugi, Hisashi
The synthesis and anti-Helicobacter pylori activity of a novel cephem derivative FR182024 (1) are described. FR182024 having a (5-methyl-1,3,4-thiadiazol-2-yl)-thio moiety at the 3-position and a phenylacetamido at the 7-position was found to have extremely potent in vitro anti-H.pylori activity, superior therapeutic efficacy to AMPC and CAM, and low potential for causing diarrhea.
View MoreDisynthesis Chemical Technology Co. Ltd.
Contact:+86-571-88194596
Address:Dengyun road 380, Gongshu district, Hangzhou city, China
FREEBARQUE DEVELOPMENT GROUP LIMITED
Contact:+86(0)10-5109 5335 or 5109 5345
Address:Room602,Block1-B,LINGDI OFFICE,NO.13 BEIYUAN ROAD
Nanjing Habo Medical Technology Co., Ltd.
Contact:025－85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
Contact:+86-511-88790000
Address:338 North Yushan Rd, Zhenjiang, Jiangsu 212016
Tianjin Tensing Fine Chemical Research Develop Centre
Contact:86-022-23718576,13032267585
Address:2-2-201,13 Guiyuan road,Huayuan Industry district,Tianjin,china
Doi:10.1016/0031-9422(96)00242-7
(1996)Doi:10.1039/b912325c
(2009)Doi:10.1016/0020-1650(68)80164-3
(1968)Doi:10.1016/S0022-328X(96)87021-5
(1996)Doi:10.1007/BF00702025
()Doi:10.1039/dt9960002541
(1996)
